Newbridge Financial Services Group, Inc. Zynerba Pharmaceuticals, Inc. Transaction History

Newbridge Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	SELL	$0.33 - $1.39 $330 - $1,390	-1,000 Reduced 21.69%	3,610 $4,000
Q2 2023 Jul 21, 2023	SELL	$0.3 - $0.43 $439 - $629	-1,465 Reduced 24.12%	4,610 $1,000
Q4 2021 Jan 19, 2022	BUY	$2.88 - $4.3 $17,179 - $25,649	5,965 Added 5422.73%	6,075 $17,000
Q2 2021 Sep 07, 2021	BUY	$3.83 - $5.98 $421 - $657	110 New	110 $1,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.